AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

BIOGEN INC. Director's Dealing 2022

Nov 21, 2022

30291_dirs_2022-11-21_28bb9248-9851-4c5e-821d-4675cd40a214.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2022-11-14

Reporting Person: Viehbacher Christopher (Director, President and CEO)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	7000	Direct